← Return to examples
Source-backed composite
A food business is about to approve a supplier, importer, label, SKU, formula change, or co-packer release. The decision risk appears where documents meet operations: supplier files, artwork versions, allergen controls, line clearance, and lot traceability.
Hold / Controls
Hold the approval or proceed only with controls. The release gate is not ready until supplier risk, label accuracy, allergen control, co-packer evidence, and lot isolation line up at the same time.
Decision Card
Decision at risk
Approving a new supplier, imported ingredient, co-packer, label/artwork variant, formula change, or shipment release after a supplier quality exception.
Failure mode
Release Approval Before Evidence Alignment
Also called: Label/Recipe Mismatch / Supplier Verification Gap / Lot Isolation Weakness
Core risk
Each document may look acceptable in isolation while the combined supplier, label, co-packer, and lot record cannot prove the product is release-ready.
Public-safe basis
A source-backed composite using FDA supplier verification, FSVP, recall, warning-letter, and import-alert patterns without naming a target company.
The Finding
The approval chain is not blocked by one dramatic defect. It is blocked by the absence of one reconciled release record. Supplier approval, label review, formula control, co-packer sanitation, and traceability are often reviewed by different people at different times.
Faultline treats those separate reviews as one pre-shipment decision. If any link changes after approval, the packet asks whether the product can still be traced, isolated, and defended before it leaves the building.
Failure Chain
1
A supplier, formula, label, or co-packer change is approved through normal document flow.
2
One evidence layer changes: ingredient spec, artwork version, allergen matrix, line assignment, or supplier file status.
3
Release proceeds because no single owner sees the full supplier-label-lot chain.
4
The gap surfaces later as a label, allergen, import-verification, co-packer, or traceability issue that should have been gated before shipment.
The Diagnostic
1
Reconcile formula, ingredient specification, label artwork, ingredient statement, allergen declaration, and revision history.
2
Review supplier approval and FSVP-style records against current risk, supplier performance, and relevant public compliance history.
3
Match co-packer allergen matrix, sanitation records, changeover SOPs, and line-clearance proof to the exact product family.
4
Run or review a mock recall showing lot isolation by input, supplier, SKU, batch, and ship-to destination.
Traceability should be proven before release, not discovered during a recall.
Decision Thresholds
The launch can proceed only when supplier, label, allergen, co-packer, and lot evidence are aligned before shipment.
| Signal |
Interpretation |
Packet action |
| Records do not reconcile |
Formula, ingredient spec, artwork version, or allergen declaration conflicts with release evidence. |
Hold until QA and regulatory sign the reconciliation. |
| Supplier file stale |
Supplier risk evaluation is missing, stale, or not tied to current hazard and performance evidence. |
Hold under supplier-verification review. |
| Co-packer proof incomplete |
Changeover, sanitation, or line-clearance evidence does not match the product family. |
Proceed only after line-level proof is complete. |
| Lot isolation weak |
The business cannot isolate affected supplier, batch, SKU, and destination quickly. |
Redesign release controls before shipment. |
| Evidence aligned |
Dual label review, supplier verification, line-clearance proof, and mock recall are complete. |
Proceed with controls. |
Evidence Gaps To Close
Supplier riskApproved supplier file, risk-based evaluation, COAs, testing history, supplier changes, and public compliance checks.
Label and formulaArtwork, ingredient statement, formula, allergen declaration, and revision history reconciled to the release SKU.
Co-packer controlsLine assignment, allergen matrix, sanitation record, changeover proof, and line-clearance evidence.
TraceabilityMock recall and lot isolation by supplier, input, batch, SKU, and ship-to destination.
Safer Path Forward
Convert the supplier, label, and co-packer checks into one release gate. Block shipment if supplier status, label version, formula, allergen matrix, line assignment, or lot traceability changes after approval.
What Would Change This Recommendation
- Completed risk-based supplier evaluation tied to the current ingredient and product risk.
- Label, formula, artwork, and allergen reconciliation signed by QA and regulatory.
- Independent allergen declaration check.
- Co-packer line-clearance and sanitation evidence for the exact product family.
- Mock recall showing traceability by lot, input, supplier, SKU, and ship-to destination.
- Release gate that blocks shipment if supplier or label evidence changes after approval.
Public Source Boundary
Composite framing
This page is a source-backed composite for food manufacturers, importers, private-label brands, retailers, and co-packer approval workflows. It does not claim that a specific company would have avoided a recall with Faultline.
The source pattern is operational: FDA supplier-verification and FSVP expectations, public recall records involving undeclared allergens or contamination, and public supplier-compliance signals should be reviewed before product release.
Evidence status: Anonymized public-safe demo. No non-public supplier file or named-company accusation is included.